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ABSTRACT
Problem: Fetal Alcohol Syndrome (FAS) is preventable, under-diagnosed, and under-reported. Wisconsin
rates for alcohol use and binge drinking in childbearing-age women exceed the national average. FAS prevalence in Wisconsin has not previously been systematically evaluated.
Methods: The Wisconsin Fetal Alcohol Syndrome
Screening Project (WFASSP) used a multi-stage, multisource prospective population-based screening methodology to identify children born in 1998-1999 in
Southeast Wisconsin who met a surveillance case definition for FAS. The 4-stage methodology used screening of electronic birth files, abstraction of neonatal
medical records, and direct assessment of facial features, growth, and development at age 2 to 3 years.
Results: The FAS prevalence rate was 0.23 per 1000
births. Children directly evaluated had fewer demographic, pregnancy, and maternal substance use risk
factors than lost-to-follow-up children. Thirty-two
percent of children with weight and head circumference below the 10th percentile at birth were developmentally delayed and 47% had at least one physical
growth delay.
Conclusions: The WFASSP methodology identified
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children who had not previously been diagnosed with
FAS. Using the combination of weight and head circumference below the 10th percentile at birth is a useful methodology for identifying children at substantial
risk for growth and developmental delays from FAS or
other unspecified etiologies.
INTRODUCTION
Fetal Alcohol Syndrome (FAS) is a leading cause of
preventable birth defects and developmental disabilities1 that results in long-term physical, cognitive and
developmental deficits.2 While the prevalence of any alcohol use among pregnant women has decreased from
16.3% in 1995 to 12.8% in 1999, the rates of binge
drinking (2.9% in 1995 and 2.7% in 1999) and frequent
drinking (3.5% in 1995 and 3.3% in 1999) reported by
pregnant women has remained largely unchanged.3
Data from the Behavioral Risk Factor Surveillance
System indicate that binge drinking (defined as 5 or
more drinks on an occasion, 1 or more times per
month) rates for Wisconsin women are consistently
well above the national average and have increased
from 1990 to 2002 (Wisconsin: 11.2% to 15.5%; United
States: 6.5 to 8.1%).4 While women typically reduce alcohol consumption during pregnancy,5 these rates are
alarming.
Current population-based systems in Wisconsin
(Birth certificate data, Birth Defects Outcomes
Monitoring Program) underestimate the prevalence of
alcohol consumption in pregnant women and the number of children with FAS. In 2002, only 1.1% of
women responded affirmatively to drinking during
pregnancy on a self-report question on the birth certificate form. The Wisconsin electronic birth file reports
only to the first decimal for International Classification
of Disease (ICD) codes.6 Yet, for 1998 and 1999, only
0.03% and 0.02% of birth records included ICD-9
code 760.7, which captures noxious influences affecting
the fetus from alcohol consumption, substance use, or
other sources.
FAS is the most serious of a constellation of possible
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outcomes associated with prenatal alcohol exposure
that have recently been aggregated under the umbrella
term Fetal Alcohol Spectrum Disorder (FASD).7 FASD
includes the range of outcomes associated with all levels of prenatal alcohol exposure and includes FAS, alcohol-related birth defects (ARBD), and alcohol-related
neurodevelopmental disorder (ARND). Risk factors
associated with FASD in addition to alcohol dose, pattern of intake, and timing of exposure during pregnancy include co-exposure to other teratogens and environmental contaminants (eg smoke, lead), high parity,
low socioeconomic status, race, poor nutrition, poor
health, and increased stress. It is clear that the influences are multifactorial and interdependent.8-9
Prevalence estimates for FAS vary widely reflecting
the methodologic challenges in case-finding, sampling,
differing study designs, inconsistencies in diagnosis,
and variation in birth defects reporting. Previous studies have used a variety of passive surveillance and active
case ascertainment methods to estimate the prevalence
of FAS in general and selected high-risk populations.8,10
Under-reporting and inaccuracy are major concerns
due to variation in the level of provider training to
identify FAS, inconsistent criteria applied to case definition, and biases related to diagnostic labeling and
stigmatization.8,11 Birth defects registries often have a
preponderance of cases enrolled from the first year
after birth. Diagnosis of FAS is most accurate between
ages 3 and 1210 and often is not diagnosed or documented in newborns even in the presence of identifying
characteristics.12 Overestimation of general population
prevalence may occur if the study cohort represents a
high-risk population. Active case ascertainment is a
population-based approach that uses active review of
records from a variety of sources (medical, school, etc)
and direct methods of diagnosis to identify children
with case characteristics. More cases are detected than
with passive surveillance due to its multi-source
methodology.13 Published prevalence estimates have
ranged from less than 1 per 1000 births for general birth
cohorts to more than 10 per 1000 births for high-risk
populations.8,10,14 The estimated prevalence rate for the
United States is between 0.5 and 3.0 per 1000 live
births.8,10 The rate for all measurable effects (FAS,
ARBD, ARND) is estimated to be 1% or more.10
In 1997, the Centers for Disease Control and
Prevention (CDC) awarded funds to 5 states under a
cooperative agreement to develop population-based
FAS surveillance systems using a multi-source methodology.15 FASSNet (Fetal Alcohol Syndrome Surveillance
Network), a standardized, multi-source surveillance
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method was developed for use in data collection.
Alaska, Arizona, Colorado, and New York used a
multi-source retrospective record-based case review
approach. Prevalence ranged from 0.3 to 0.4 per 1000
births in 3 states and 1.5 per 1000 births in Alaska for a
combined prevalence estimate of 0.4 per 1000 births.16
METHODS
The Wisconsin Fetal Alcohol Syndrome Surveillance
Project used a prospective, multi-source, multi-stage
active case ascertainment system to identify children
who met diagnostic criteria for fetal alcohol syndrome.
Each successive screening stage assessed one of the project’s case selection criteria. The case selection criteria
for the WFASSP and FASSNet were both based on the
1996 Institute of Medicine (IOM) Report on FAS.8 The
IOM FAS diagnostic criteria, FASSNet case definition,
and the WFASSP case selection criteria for each screening stage are presented in Table 1.
The birth cohort for the project consisted of infants
born in 1998 and 1999 in 22 birth hospitals to mothers
resident in an 8-county southeast region of Wisconsin.
This region included urban, suburban, and rural households. In the first screening stage, cases were selected
using the electronic birth file from the Wisconsin
Bureau of Health Information. Cases selected in Screen
1 were small for gestational age, defined as birth weight
below the 10th percentile (BWT<10th) based on sex
and gestational age-specific reference values from the
1991 US Live Birth File.17 To adjust for the expected
lower birth weight values for low risk African
American infants,18 10th percentile cut-offs for African
American infants (based on maternal race category on
the birth certificate) were 200 g less than those for other
infants.
In Screen 2, neonatal medical records were abstracted for birth head circumference (BHC), gestational age, evidence of maternal alcohol use or other
FAS case criteria, and contact information (for use in
the next screening stage). Medical records for children
who were adopted or had died were not abstracted.
Newborns with BHC less than gestational age-specific
10th percentile (BHC<10th)19 were retained for the
next screen level.
Families of children with positive findings (BWT
and BHC<10th) were contacted when the child was between 2 and 3 years old. Following IRB approvals and
after securing a Certificate of Confidentiality from the
National Institute of Alcohol Abuse and Alcoholism,
parents were contacted by letter of introduction and
subsequently by telephone to discuss participation in
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Table 1. Institue of Medicine, Fetal Alcohol Syndrome Surveillance Network and Wisconsin Fetal Alcohol Syndrome Screening
Project Case Definitions
*Institute of Medicine FAS Diagnostic
Criteria for Category 2:FAS without
confirmed maternal alcohol exposure

†

Evidence of growth retardation, as in
at least one of the following:
a. Low birth weight for gestational age
b. Decreasing weight over time not due
to nutrition
c. Disproportional low weight for height

Growth criteria:
Intrauterine weight or height corrected for
gestational age <10th percentile
Or
Postnatal weight or height <10th percentile
Or
Postnatal weight for height <10th percentile

Screen #1:
Birth weight <10th percentile corrected
for gestational age and race

Evidence of CNS neurodevelopmental
abnormalities, as in at least one of the
following:
a. Decreased cranial size at birth
b. Structural brain abnormalities (eg microcephaly, partial or complete agenesis of the corpus collosum, cerebellar
hypoplasia
c. Neurological hard or soft signs (as
age appropriate) such as impaired
motor function skills, neurosensory
hearing loss, poor tandem gait, poor
eye-hand coordination

Central Nervous System (CNS) criteria:
Frontal-occipital circumference <10th percentile at birth or at any age
Or
Standardized measure of intellectual
function <1 standard deviation (SD)
below the mean
Or
Standardized measure of developmental
delay <1 standard deviation (SD) below
the mean
Or
Developmental delay or mental retardation diagnosed by a qualified medical examiner (eg psychologist or physician)
Or
Attention deficit disorder diagnosed by a
qualified evaluator

Screen # 2:
Gestational-age specific frontal-occipital
circumference <10th percentile at birth

Evidence of a characteristic pattern of
facial abnormalities that includes:
a. Features such as short palpebral fissures, and
b. Abnormalities in the premaxillary zone
(e.g. flat upper lip, flattened philtrum,
and flat midface

Face criteria:
Abnormal facial features consistent with
FAS as reported by a physician
Or
Two of the following:
• Short palpebral fissures
• Abnormal philtrum
• Thin upper lip

Screen # 3:
Two of the following:
• Short palpebral fissures
• Abnormal philtrum
• Thin upper lip

FASSNET Case Definition Criteria:
Confirmed FAS phenotype with or
without maternal alcohol exposure‡

WFASSP Case Selection Criteria

*Source: Institute of Medicine8
Source: Hymbaugh et al15
‡
Documentation in the records of some level of maternal alcohol use during the index pregnancy.

†

the direct assessment stage. Screen 3 consisted of assessment of facial features of the FAS phenotype, and measurements of growth (weight, height, head circumference) and development (Denver Developmental
Screening Test II [DENVER II]). All assessments in
this screen level were carried out by graduate nursing
students at Marquette University College of Nursing,
and completed either at the Marquette Infant
Assessment Lab (44%) or at the family’s home (56%).
Assessors had received 16 hours of training in procedures used for subject contact and enrollment, growth

measurements, developmental assessment, and evaluation of facial phenotype.
Facial features were assessed by 2 independent observers using the Astley-Clarren philtrum and lip
chart.20 Scores of 4 or 5 were considered positive for
features characteristic of the FAS phenotype. Palpebral
fissure length was measured using a clear plastic ruler
following a technique described by Hall et al.21 Two
measurements of each eye were taken by each of 2 observers. The child was considered positive for the feature if the smallest of the measurements was below the
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Table 2. Demographic, Pregnancy, and Substance Use Risk Factors for WFASSP Birth Cohort and Screening Levels
Birth Cohort
N
Smoking
Alcohol Use
Illicit Drug Use
Alcohol or Drug
African American
Milwaukee County
Unmarried
Mother < 20 Years
< High school Graduate
Inadequate Prenatal Care
<36 Weeks Gestation

56,257
16%
2%
2%
NA
21%
53%
36%
13%
20%
4%
11%

Screen 1: BWT
<10th Percentile
3291
33%
3%
4%
6%
19%
56%
45%
17%
26%
8%
15%

Screen 2:BWT & BHC
<10th Percentile

Screen 3:
Seen

615
31%
4%
6%
8%
35%
63%
54%
18%
29%
9%
19%

177
21%
7%
5%
10%
21%
57%
40%
14%
17%
3%
22%

Screen 3:
LTFU
438
32%
13%
13%
19%
40%
66%
60%
20%
34%
11%
18%

BWT=birth weight; BHC=birth head circumference;LTFU =lost to follow up; NA =not available.

10th percentile.21 The child met the case criteria for FAS
if 2 of the 3 facial criteria were positive (philtrum, lip,
eyes).
Growth measurements and developmental assessments were also completed for all children seen at
Screen 3. Anthropometric measurement followed methods described by Lohman and coworkers.22 Weight was
measured using a calibrated scale and recorded to the
nearest 0.1 kilogram. Recumbent length was measured
to the nearest millimeter (mm) using a recumbent length
board. Head circumference was measured to the nearest
mm using a non-flexible tape. All measurements were
repeated twice by 2 observers, and the 2 closest measurements were averaged. The DENVER II was completed by 2 observers and followed procedures outlined
in the DENVER II training manual.23 Children with 2
FAS facial characteristics were referred for dysmorphology evaluation, further developmental testing, and assessment of maternal alcohol use (Screen 4).
In addition to the prospective screening methodology described above, a retrospective case ascertainment
approach similar to the methodology of the other 4
FASSNet state projects15 was used to evaluate whether
the WFASSP screening methodology missed cases documented in other sources. Records for all children in
the birth cohort who had received inpatient or outpatient services at Children’s Hospital of Wisconsin were
screened for the study’s case selection criteria. ICD-9
codes for FAS, microcephaly, and maternal substance
use were used as the initial search strategy. Records
were then abstracted for the same case selection criteria
as the WFASSP prospective methodology.
RESULTS
The birth cohort for the project consisted of 56,247 in56

fants. A total of 3291 (6% of the birth cohort) met
Screen 1 criteria and were selected for Screen 2 medical
record abstraction. Of the records reviewed for Screen
2, weight or gestational age for 38 neonates (1.2%) had
been misreported to the state vital records office, and
did not meet the criterion of BWT<10th. Of the remaining records, a total of 615 cases met Screen 2 criteria (19% of Screen 1 cases, representing 1% of the birth
cohort) and were eligible for Screen 3 assessment. Of
cases eligible for participation in Screen 3, 177 (29%)
agreed to participate (referred to as Screen 3 Seen), and
438 (71%) were lost to follow-up (referred to as Screen
3 LTFU). Three hundred and six children (50%) could
not be located, 130 (21%) parents refused, and 18
(0.3%) were excluded for other reasons (died, moved).
Screen 3 assessments were completed at an average of
28 months of age (range 21-41 months).
Demographic and pregnancy risk factors were obtained from the electronic birth file and used to compare the characteristics of children at each screening
stage. Compared with the birth cohort, the Screen 2
(BWT and BHC<10th) children were more likely to
have been exposed to smoking, alcohol use, and illicit
drug use in utero, and had higher rates of demographic
and pregnancy risk factors than the birth cohort (Table
2). Children evaluated (Seen) in Screen 3 had fewer demographic and pregnancy risk factors than those who
were lost to follow-up and a lower rate of smoking, alcohol, and illicit drug use.
Thirteen children evaluated in Screen 3 met the case
criteria for FAS, yielding a prevalence estimate of 0.23
per 1000 births. Three of these children had evidence of
alcohol exposure during pregnancy in the electronic
birth record or neonatal medical record. None of the
children meeting the FAS case definition had documen-
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Table 3. FAS Diagnostic Criteria and Follow-up Growth and Development Delays Present in Children (n=13) Who Met the FAS
Case Definition
Birth
Measurements
Subject #
1
2
3
4
5
6
7
8
9
10
11
12
13

BWT BHC
<10th < 10th
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+
+
+

Alcohol Use
in Pregnancy

Measurements at Age 2-3 Years
WT
HC
<10th < 10th
+
+

+
+

+
+
+

+

+
+

+

+

+
+

Lip

Philtrum

+
+
+
+

+
+
+
+
+
+

+
+
+
+
+
+
+

+
+
+
+

Palpebral
Fissures

DENVER II
Delay

+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+

Reported on
Birth Certificate

Reported in
Other Source *
+

+

+
+

+

* Maternal/neonatal medical record or verbal report at Screen 3 Evaluation; BHC=Birth head circumference; BWT=Birth weight.

tation of microcephaly in the neonatal medical record
or in the electronic birth file, and none had been previously diagnosed with FAS. Table 3 displays findings for
case selection criteria and follow-up growth and development assessment for the 13 children meeting the FAS
case definition. These children were referred to a dysmorphologist for Screen 4 assessment and diagnosis.
Among the children evaluated in Screen 3, nearly a
third (31.6%) were classified as suspect (i.e. delayed) on
the DENVER II. The most common deficit subscale
was language, followed by gross motor, personal-social,
and fine motor skills (Figure 1). Nearly two-thirds
(66%) were delayed on 2 or more subscales. Fortyseven percent of the children seen for Screen 3 evaluation had at least 1 physical growth measurement less
than the age- and sex-specific 10th percentile. Weight
(36.9%) was the most commonly restricted physical
growth parameter. Of children with developmental delays, 62% also exhibited at least 1 physical growth
delay. Z scores for height, weight, head circumference,
and weight for height were all significantly lower for
children with developmental delays than for children
without evidence of delay on the DENVER II (Table 4).
In the retrospective case review, 23 children with a
clinical diagnosis of FAS were identified. Of these, 7
met the Screen 1 criteria, 2 met the Screen 2 criteria but
could not to be located for Screen 3 follow-up, and
none met the criteria for the FAS case definition.
DISCUSSION
Using a multistage screening ascertainment system, 13

cases of FAS were identified out of a birth cohort of
56,247 (prevalence estimate 0.23 per 1000 births). This
rate is similar to rates reported in previous studies, but
lower than those reported by the majority of other
states in the FASSNet project that used a retrospective
record-based multi-source methodology (Table 5).15
The Wisconsin rate was lower than 3 of the 4 FASSNet
states but was within the 95% confidence interval of 1
of the states (Colorado).
The prevalence rate documented by the WFASSP is
likely a conservative estimate of the true prevalence of
FAS in Wisconsin. The screening methodology using
BWT and BHC<10th as the first 2 screening parameters identified a subset of children with a higher risk
profile for FAS as well as growth and development
deficits when compared with the birth cohort. A selection bias was evident in the children seen for Screen 3
evaluation. The Screen 3 Seen children had fewer demographic, pregnancy, and maternal substance use risk
factors than the children who were lost to follow-up. It
is likely that the rates of FAS, physical growth delay,
and developmental delay would be higher if the entire
group of children eligible for Screen 3 assessment were
evaluated.
A number of important differences between
Wisconsin and the other 4 states in the FASSNet surveillance project may account for differences in prevalence estimates. The WFASSP used more restrictive
case selection criteria than the other FASSNet states.
The Wisconsin case criteria used BWT and BHC <10th
while the FASSNet case definition adopted by the
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50%
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Figure 1. Percent of developmental delayed children (N=56)
with co-occurring growth measurements less than 10th percentile at age 2-3 years.

Table 4. Comparison of Z Scores for Growth Measurements in
Children With and Without Developmental Delay
GM

DD

N

Z

SD

Height

No
Yes

113
52

-0.42
-0.78

0.88
0.92

2.36 163 0.02

Weight

No
Yes

116
54

-0.66
-1.22

1.09
1.09

3.10 168 0.002

Head
No
Circumference Yes

112
51

-0.29
-0.84

0.88
1.14

3.40 161 0.001

Weight
for Height

113
51

-0.43
-0.91

1.05
1.07

2.67 162 0.009

No
Yes

t

df

p

GM=growth measure; DD=developmental delay; Z=mean Z
score; SD=standard deviation

Table 5. Prevalence of FAS (per 1000 Births, ± 95% Poisson
Confidence Interval) by State
Rate per Lower Upper
# Cases # Births 1000 Births
Cl
Cl
Alaska*
Arizona*
Colorado*
New York*
Wisconsin

45
75
25
40
13

30,284
223,043
95,136
88,789
56,257

1.49
0.34
0.26
0.45
0.23

1.05
0.26
0.16
0.31
0.11

1.92
0.41
0.37
0.59
0.36

*Source: CDC16

other 4 states used BWT and BHC equal to or less than
the 10th percentile. In addition, the other states permitted inclusion as a case if 1 of several growth or central
nervous system (CNS) parameters met the case definition criteria at any age in the surveillance period.
Because 1 of the goals of the Wisconsin project was to
test a multi-stage screening approach that might promote earlier detection of FAS, inclusion as a case required that the growth and CNS criteria be met at
birth. This, however, excluded any children who exhib-
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ited normal weight or head circumference at birth but
had subsequent below-normal growth patterns. The
Wisconsin approach evaluated children at 2 to 3 years
of age. In the other states in the project, data were collected for a 1995 to 1997 birth cohort with a 2- to 4year post-birth period for case-finding,15 giving more
opportunity for case identification. For these reasons, it
is not unexpected that the prevalence rate for
Wisconsin is at the lower end of the range for FASSNet
states.
None of the Wisconsin children identified through
the prospective screening methodology had been previously diagnosed. In the retrospective case review for
additional cases not identified by the screening
methodology, 23 cases were found, with no duplication
from the prospective screening method. While the retrospective method identified children with an established clinical diagnosis, the Wisconsin method identified children who had not been referred for evaluation
of FAS. Thus, these 2 ascertainment methods identify
different children. Combining the multi-source detection strategies offered by the Wisconsin prospective ascertainment approach and the records-based surveillance of the other FASSNet states would provide a
comprehensive strategy for prevalence estimation and
population-based surveillance of FAS. A clear advantage of the prospective approach is that it provides an
opportunity to combine case finding for surveillance
purposes with early detection and initiation of intervention.
The children who screened positive in Screen 3 met
the case definition for FAS without confirmed maternal
alcohol exposure (IOM Category 2).8 The source data
for maternal alcohol use was the State of Wisconsin
electronic birth file and abstracted neonatal medical
records. Only 3 out of 13 cases had evidence of alcohol
exposure documented in these sources. Maternal alcohol exposure is substantially underreported in birth
records.24 In the study sample, 3% of mothers in Screen
1 (BWT<10th) and 4% in Screen 2 (BWT and
BHC<10th) reported any alcohol use during the pregnancy. These data indicate substantial underreporting
of the prevalence of prenatal alcohol exposure compared to BRFSS data for Wisconsin and the nation.
No children who met the case definition completed
the follow-up referral to the dysmorphologist despite
active attempts to schedule appointments. Some mothers reported that they were already connected with a
pediatric specialist for another medical problem. For
others, costs of transportation, difficulties with childcare and work schedules, and insurance issues inter-
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fered with completion of the diagnostic process. In future early identification and intervention programs for
FAS, services to assist families with the logistics of diagnosis and intervention will be necessary.
Persistent growth and development deficits have
been widely reported for FAS children2,8 and were documented in this study. Of particular interest are the
rates of growth and development delays found in children who were positive on the first 2 screening criteria
(BWT and BHC<10). Without consideration of facial
feature characteristics of FAS, these 2 criteria identify a
group of children at high risk for growth and developmental delays that persist through age 2. Kirby25 has
noted the importance of recording and monitoring the
co-occurrence of birth defects and developmental disabilities to better understand their overlapping nature
and differentiate between perinatal outcomes, postnatal
etiologies, and normative growth and development of
children with birth defects. In this study we were able
to assess the developmental outcomes of co-occurrence
of BWT and BHC<10th, with results indicating that
nearly one-half had persistent physical growth delays
and one-third had developmental delays. Co-occurrence of persistent growth delays occurred in 62% of
cases with developmental delays.
The etiology for the CNS (BHC<10th) and growth
(BWT<10th) deficits at birth and the high rates of developmental delay, growth delay, and co-occurrence of
growth and developmental delays persisting at age 2 to
3 years are unknown among this study population. It is
possible that these findings reflect a range of effects
from alcohol use. However, because of the incomplete
documentation of maternal alcohol use, the relationship between alcohol use and the study findings cannot
be evaluated adequately. Other etiologies were undoubtedly involved in developmental and growth delays in these children. Regardless of the etiologies, the
group of children screened using this method represent
children at substantial risk for persistent growth and
development delays who would benefit from early intervention. Unfortunately, mothers of children with
developmental delays in this study rarely reported referral to or participation in any kind of developmental
follow-up or intervention program.
A number of factors may have limited the reliability
of the prevalence estimate. The high lost-to-follow-up
rate may have resulted in under-ascertainment of FAS
cases. Risk factor data indicated that lost-to-follow-up
children were at greater risk for FAS and postnatal
growth impairment and developmental delays. The
major reason for loss to follow-up was use of birth

record contact information to locate parents 2 years
after the birth. Children who were adopted at birth or
who were in foster care were not evaluated and may
also represent a group at higher risk for FAS.14 This
methodology also missed any FAS cases where growth
and CNS criteria were not present at birth. Children in
this study who met the Screen 3 criteria met the case selection requirements for both the IOM and FASSNet
case definitions but did complete the Screen 4 clinical
diagnosis stage. Systematic assessment of prenatal alcohol exposure was also a planned component of the
Screen 4 evaluation. Consequently, all cases identified
in this study can be classified as FAS without confirmed alcohol exposure (IOM Category 2)8 or confirmed FAS Phenotype without documentation of in
utero alcohol exposure (FASSNet case definition).15
The difficulty in referral and completion of the clinical
diagnostic process underscores the problems with obtaining accurate prevalence estimates.
The WFASSP methodology has several clear
strengths for identifying FAS cases. Screens 1 and 2
used measurements routinely obtained on neonates at
birth. Because these measurements also identified individuals at risk for developmental and growth delay,
they could be used as a cost-effective first level screen
for at-risk infants including those with FAS. Second,
early identification of at-risk infants (Screens 1 and 2)
allows secondary and tertiary prevention to be effectively instituted. Third, the criteria used to identify features of FAS were consistent across all cases, and all assessments had documented high reliabilities.
RECOMMENDATIONS
The results of this study suggest that using a simple
screening approach beginning with identification of 2
of the FAS case definition criteria (BWT and BHC
<10th percentile), which are commonly available at the
time of birth to providers and public health workers,
offers the opportunity to initiate a surveillance process
for children at risk for FAS and/or developmental and
physical growth delays. Better documentation of prenatal alcohol exposure and FAS characteristics at birth
will reduce under-reporting of this birth defect and
promote better case finding for early intervention.
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